Evidence map›Paper›PMID 41499022›Full record

ArticleJournal of mammary gland biology and neoplasia2026

Increased Toll-Like Receptor-4 Signalling in Breast Tissue of High Fibroglandular Density.

Hanieh Heydarlou, Leigh J Hodson, Pallave Dasari, Eric Smith, Wendy V Ingman

Abstract read
In one paragraph

Article in Journal of mammary gland biology and neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hanieh HeydarlouSchool of Medicine, Adelaide University, The Queen Elizabeth Hospital, DX465702, 28 Woodville Rd, Woodville, Adelaide, 5011, Australia.
Leigh J HodsonSchool of Medicine, Adelaide University, The Queen Elizabeth Hospital, DX465702, 28 Woodville Rd, Woodville, Adelaide, 5011, Australia.
Pallave DasariSchool of Medicine, Adelaide University, The Queen Elizabeth Hospital, DX465702, 28 Woodville Rd, Woodville, Adelaide, 5011, Australia.
Eric SmithSchool of Medicine, Adelaide University, The Queen Elizabeth Hospital, DX465702, 28 Woodville Rd, Woodville, Adelaide, 5011, Australia.
Wendy V IngmanSchool of Medicine, Adelaide University, The Queen Elizabeth Hospital, DX465702, 28 Woodville Rd, Woodville, Adelaide, 5011, Australia. wendy.ingman@adelaide.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High mammographic breast density relates to the abundance of fibroglandular tissue in comparison to fatty tissue in the breast and is associated with increased breast cancer risk. Chronic low-level inflammation has been implicated as a driver of high density and cancer risk, however little is understood of the underlying cause of inflammation. This research aimed to investigate the role of the innate immune recognition receptor toll-like receptor-4 (TLR4) in inflammation associated with high fibroglandular density. Immunohistochemical analysis was performed on paired breast tissue samples of high and low fibroglandular density tissue (n = 22 pairs) to investigate the expression of TLR4, TLR4 agonists lipopolysaccharide (LPS) and damage response protein high-mobility group protein 1 (HMGB1), as well as activation of downstream mediators myeloid differentiation primary response 88 (MYD88) and nuclear factor kappa B (NFKB). Mammary epithelial cell organoids (n = 5) were cultured in vitro with LPS to investigate the expression of genes associated with inflammation. TLR4 was primarily expressed in basal epithelial cells, stromal macrophages, and some expression was detected in luminal epithelial cells. Increased expression of TLR4, MYD88, NFKB, and HMGB1 was observed in epithelial cells in high fibroglandular density tissue. There was increased expression of the genes encoding inflammatory cytokines tumour necrosis factor alpha (TNFA) and C-C motif ligand 2 (CCL2) in mammary epithelial cell organoids treated with LPS. The TLR4 signalling pathway may be a mediator of local breast inflammation associated with regions of high breast density and the damage response protein HMGB1 may be a trigger for TLR4 activation.

Indexed as

Breast DensityBreast NeoplasmsMammary Glands, HumanToll-Like Receptor 4FemaleHMGB1 ProteinHumansInflammationLipopolysaccharidesMiddle AgedMyeloid Differentiation Factor 88NF-kappa BSignal TransductionHMGB1 ProteinLipopolysaccharidesMYD88 protein, humanMyeloid Differentiation Factor 88NF-kappa BTLR4 protein, humanToll-Like Receptor 4Breast cancer riskCytokinesInflammationMammographic densityToll-like receptors

Identifiers

PMID41499022
PMCPMC12872694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.